Workflow
aTyr Pharma(LIFE)
icon
Search documents
Defiance Silver Corp. Announces Upsize of the Brokered LIFE Offering and Non-Brokered Private Placement for Aggregate Gross Proceeds of up to C$14.5 Million
Newsfile· 2025-06-05 19:16
Defiance Silver Corp. Announces Upsize of the Brokered LIFE Offering and Non-Brokered Private Placement for Aggregate Gross Proceeds of up to C$14.5 MillionJune 05, 2025 3:16 PM EDT | Source: Defiance Silver Corp.Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Defiance Silver Corp. (TSXV: DEF) (FSE: D4E) (WKN: A1JQW5) (the "Company", or "Defiance") is pleased to announce that, as a result of strong investor demand, the Company has increased the size of its previously announced " ...
Defiance Silver Corp. Announces Brokered LIFE Offering for Gross Proceeds of up to C$8 Million
Newsfile· 2025-06-04 21:23
Core Viewpoint - Defiance Silver Corp. has announced a brokered private placement offering to raise gross proceeds of up to C$8 million through the sale of up to 32 million units at a price of C$0.25 per unit [1][2]. Group 1: Offering Details - Each unit will consist of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at a price of C$0.35 within 24 months following the closing date [2]. - The company grants the agent an option to sell up to an additional 8 million units for additional gross proceeds of up to C$2 million [3]. - The offering is scheduled to close on June 17, 2025, subject to regulatory approvals [8][9]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for exploration work on the company's projects, completing a mineral resource estimate at the San Acacio project, making cash option payments on the Tepal project, and providing general working capital [4]. Group 3: Regulatory Compliance - The units will be offered to purchasers in specific Canadian provinces under the Listed Issuer Financing Exemption, and may also be sold in offshore jurisdictions and the United States under applicable exemptions [5][7]. - All securities not issued under the Listed Issuer Financing Exemption will be subject to a hold period of four months and one day following the closing date [7]. Group 4: Company Overview - Defiance Silver Corp. is focused on advancing the Zacatecas project and the Tepal Gold/Copper Project in Mexico, managed by a team with a proven track record in mine development [11].
Ucore Announces Brokered LIFE Offering of Units for up to $10 Million
Newsfile· 2025-06-03 20:30
Core Viewpoint - Ucore Rare Metals Inc. has initiated a private placement offering to raise up to $10 million, with the potential to increase to $11.5 million if the Agents' Option is fully exercised, aimed at advancing its strategic metals complex and fulfilling obligations with the U.S. Department of Defense and Natural Resources Canada [1][2][5]. Group 1: Offering Details - The offering price is set at $1.20 per Unit, with each Unit comprising one common share and one-half of a warrant, allowing the purchase of one common share at an exercise price of $1.75 for 36 months [1]. - The Agents' Option allows for the sale of an additional 1,250,000 Units, potentially raising an extra $1.5 million [2]. - The offering is expected to close around June 19, 2025, pending necessary approvals [7]. Group 2: Use of Proceeds - Proceeds from the offering will be allocated to finalizing upstream mixed-rare-earth feedstock agreements and downstream customer offtake agreements for the planned strategic metals complex in Louisiana [5]. - Funds will also support the completion of existing obligations with the U.S. Department of Defense and Natural Resources Canada, commercial scale column confirmation testing, and ongoing engineering plans for the strategic metals complex [5]. Group 3: Regulatory and Market Context - The Units will be offered under the listed issuer financing exemption in Canada, excluding Québec, and will not have resale restrictions under applicable Canadian securities laws [3]. - The offering will also be available in the United States under exemptions from registration requirements, with no prospectus filing obligations in other jurisdictions [4]. Group 4: Company Overview - Ucore focuses on rare and critical metal resources, aiming to become a leading advanced technology company in metal separation products and services [11]. - The company plans to disrupt China's control over the North American rare earth element supply chain through the development of processing facilities in the U.S. and Canada [12].
Argyle Announces up to C$1 Million LIFE Offering
Newsfile· 2025-05-26 23:00
Core Points - Argyle Resources Corp. plans to complete an offering of up to 2,000,000 units at a price of C$0.50 per unit, aiming for gross proceeds of up to C$1,000,000 [1] - Each unit consists of one common share and one-half of a share purchase warrant, with the warrant allowing the purchase of one share at C$0.55 for 24 months [1] - The offering will be conducted under the listed issuer financing exemption, allowing for no resale restrictions in most Canadian provinces [2] Financial Details - The offering is scheduled to close on or about June 6, 2025, and is subject to raising a minimum of C$750,000 [4] - Proceeds from the offering will be used for general working capital purposes [4] Company Overview - Argyle Resources Corp. is a junior mineral exploration company focused on acquiring and evaluating natural resource properties in North America [6] - The company holds a 100% interest in several silica projects in Québec and has options to acquire additional properties in Ontario and Nova Scotia [6] - Established in 2023, the company is headquartered in Calgary, Alberta [7]
aTyr Pharma(LIFE) - 2025 Q1 - Quarterly Report
2025-05-07 20:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37378 ATYR PHARMA, INC. (Exact name of registrant as specified in its charter) Delaware 20-3435077 (State or other jurisdiction ...
aTyr Pharma(LIFE) - 2025 Q1 - Quarterly Results
2025-05-07 20:03
Exhibit 99.1 IMMEDIATE RELEASE Contact: Ashlee Dunston Sr. Director, Investor Relations and Public Affairs adunston@atyrpharma.com aTyr Pharma Announces First Quarter 2025 Results and Provides Corporate Update Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025. Blinded baseline demographics and disease characteristics from Phase 3 EFZO-FIT™ study and current U.S. epidemiology and treatment practices for pulmonary sarcoidosis to be present ...
GLOBE LIFE INC. REPORTS FIRST QUARTER 2025 RESULTS
Prnewswire· 2025-04-30 20:15
MCKINNEY, Texas, April 30, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2025, net income was $3.01 per diluted common share, compared with $2.67 per diluted common share for the year-ago quarter. Net operating income was $3.07 per diluted common share, above management's expectations, compared with $2.78 per diluted common share for the year-ago quarter.HIGHLIGHTS: Net income as an ROE was 19.0% for the three months ended March 31, 2025. Net operating i ...
Vortex Energy Corp. Announces Listed Issuer Financing Exemption (LIFE) Private Placement
GlobeNewswire News Room· 2025-04-24 21:00
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) announces that it intends to complete a non-brokered private placement financing (the “Private Placement”) consisting of a minimum of 2,190,000 common shares of the Company (the “Common Shares”) and up to a maximum of 4,000,000 Common Shares at an issue price of $0 ...
DiagnaMed Announces Closing of LIFE Offering
Newsfile· 2025-04-14 12:00
Each unit consists of one common share in the capital of the company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share for a period of 24 months from closing at an exercise price of $0.05. Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to a ...
LithiumBank Announces Closing of Final Tranche of LIFE Private Placement
Newsfile· 2025-04-09 00:36
Core Points - LithiumBank Resources Corp. has successfully closed the second and final tranche of its non-brokered private placement, raising approximately $2.9 million, bringing total gross proceeds to about $4.9 million [1][5] Group 1: Offering Details - Each LIFE Unit consists of one common share and one-half of a common share purchase warrant, with each warrant allowing the purchase of one share at an exercise price of $0.50 for 36 months [2] - The LIFE Units were issued under the Listed Issuer Financing Exemption, making them immediately tradeable without a hold period under Canadian securities laws [3] Group 2: Finder's Fees and Warrants - The company paid a cash finder's fee of $7,595 to Red Cloud Securities Inc. and issued 21,700 finders' warrants, while also paying $26,464.90 to Leede Financial Inc. and issuing 75,614 finders' warrants [4] Group 3: Use of Proceeds - The net proceeds from the LIFE Offering will be used for brine hosted mineral license payments, environmental assessment studies, and community consultation [5] Group 4: Company Overview - LithiumBank Resources Corp. focuses on lithium exploration in Western Canada, holding 1,855,915 acres of lithium brine licenses across Alberta and Saskatchewan, and has licensed DLE technology from Go2Lithium [7]